Baxter International, Inc. (BAX)

25.83 +0.26 (+1.02%) USD  |  NYSE  |  Sep 04, 16:00
25.80 -0.03 (-0.12%) After-Hours: 20:00
More

Baxter International SG&A Expense (TTM) : 2.932B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.932B
March 31, 2026 2.915B
December 31, 2025 2.89B
September 30, 2025 2.89B
June 30, 2025 2.936B
March 31, 2025 3.239B
December 31, 2024 3.563B
September 30, 2024 3.787B
June 30, 2024 3.777B
March 31, 2024 3.72B
December 31, 2023 3.688B
September 30, 2023 3.604B
June 30, 2023 3.801B
March 31, 2023 3.807B
December 31, 2022 3.864B
September 30, 2022 3.848B
June 30, 2022 3.587B
March 31, 2022 3.292B
December 31, 2021 2.867B
September 30, 2021 2.632B
June 30, 2021 2.553B
March 31, 2021 2.468B
December 31, 2020 2.469B
September 30, 2020 2.485B
June 30, 2020 2.511B
Date Value
March 31, 2020 2.562B
December 31, 2019 2.535B
September 30, 2019 2.496B
June 30, 2019 2.553B
March 31, 2019 2.579B
December 31, 2018 2.588B
September 30, 2018 2.653B
June 30, 2018 2.649B
March 31, 2018 2.62B
December 31, 2017 2.58B
September 30, 2017 2.551B
June 30, 2017 2.597B
March 31, 2017 2.668B
December 31, 2016 2.739B
September 30, 2016 2.809B
June 30, 2016 2.877B
March 31, 2016 2.951B
December 31, 2015 3.094B
September 30, 2015 3.221B
June 30, 2015 3.254B
March 31, 2015 3.459B
December 31, 2014 3.585B
September 30, 2014 3.779B
June 30, 2014 3.927B
March 31, 2014 3.777B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Becton, Dickinson & Co. 5.233B
DexCom, Inc. 1.361B
Boston Scientific Corp. 7.159B
West Pharmaceutical Services, Inc. 426.80M
Abbott Laboratories 13.94B